FDA panel to consider brain stimulator for epilepsy
(HealthDay News) - A U.S. Food and Drug Administration advisory panel will weigh on Friday the merits of a new therapy for some people with epilepsy who have seizures that don't respond to medication.
Neuroscience
Feb 21, 2013 |
not rated yet |
1
FDA panel votes for tougher curbs on vicodin, other painkillers
(HealthDay)—A U.S. Food and Drug Administration advisory panel voted Friday to place tougher restrictions on prescription painkillers containing hydrocodone, potentially moving medications such as Vicodin ...
Medications
Jan 26, 2013 |
1 / 5 (1) |
2
FDA panel votes for tougher restrictions on hydrocodone
(HealthDay)—A U.S. Food and Drug Administration advisory panel met Thursday and Friday to discuss the fate of certain painkillers that contain the opioid known as hydrocodone, concluding in a vote in favor ...
Medications
Jan 26, 2013 |
3 / 5 (2) |
0
FDA panel weighs tougher restrictions on some prescription painkillers
(HealthDay)—A U.S. Food and Drug Administration advisory panel will meet Thursday and Friday to discuss the fate of certain painkillers that contain an opioid known as hydrocodone.
Medications
Jan 24, 2013 |
3 / 5 (2) |
0
Scientists to resume work with lab-bred bird flu
International scientists who last year halted controversial research with the deadly bird flu say they are resuming their work as countries adopt new rules to ensure safety.
Medical research
Jan 23, 2013 |
not rated yet |
1
FDA panel recommends against 1st drug for chronic fatigue syndrome
(HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.
Medications
Dec 21, 2012 |
1 / 5 (1) |
1
|
Looking to NANA: Touch-screen technology to address malnutrition in older adults
A touch-screen computer to help detect malnutrition in older adults has been created by a team of researchers led by the University of St Andrews.
Health
Nov 08, 2012 |
5 / 5 (1) |
0
Bird flu debate: Should H5N1 experiments resume?
Virologists making mutated versions of the H5N1 bird flu halted their research in January after a U.S. government advisory panel suggested that their work, though well-intentioned, had the potential to endanger the public.
Medical research
Oct 13, 2012 |
5 / 5 (3) |
2
FDA recommends approval for Second Sight's Argus II retinal prosthesis system in the US
On Friday September 28, a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel unanimously voted 19-0 that the probable benefit of the Argus II Retinal Prosthesis System outweighs the risks to health, ...
Ophthalmology
Oct 03, 2012 |
not rated yet |
0
9/11 WTC health program adds 50 types of cancer
(AP)—The federal government will include about 50 types of cancer on the list of Sept. 11 World Trade Center-related illnesses covered by a program to pay for health coverage.
Health
Sep 10, 2012 |
not rated yet |
0
New guidelines say no to screening EKGs for low-risk patients
(HealthDay) -- A top U.S. advisory panel has recommended against preventive electrocardiography (EKG) screening for people at low risk of heart disease.
Cardiology
Jul 30, 2012 |
not rated yet |
0
|
US regulators to decide on new weight loss drug
US regulators were expected to decide Tuesday whether to approve the second new anti-obesity drug in 13 years, Qnexa, which studies have shown may help some people lose up to 10 percent of their body weight.
Medications
Jul 17, 2012 |
not rated yet |
0
Older women should not take calcium, vitamin D: task force
(HealthDay) -- A leading U.S. government advisory panel has proposed that postmenopausal women not take low-dose calcium and vitamin D supplements daily to ward off bone fractures.
Health
Jun 12, 2012 |
4.5 / 5 (2) |
1
New blood thinner may lower chances of clots in high-risk heart patients: FDA
(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.
Medications
May 21, 2012 |
not rated yet |
0
FDA panel backs first rapid, take home HIV test
(AP) -- A panel of HIV specialists is recommending that U.S. regulators approve the first over-the-counter HIV test designed to quickly return a result in the privacy of a person's own home, a new option which could expand ...
HIV & AIDS
May 15, 2012 |
not rated yet |
0
